Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Carbocisteine 750mg/10ml soln 10ml sachets sugar free
0307000J0AAAGAG
|
Carbocisteine | Carbocisteine | Respiratory System | 14,988 |
|
AirFluSal 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BGACBG
|
AirFluSal | Fluticasone propionate (Inhalation) | Respiratory System | 14,793 |
|
Piriton 4mg tablets
0304010G0BCAAAC
|
Piriton | Chlorphenamine maleate | Respiratory System | 14,649 |
|
Salbutamol 200micrograms/dose dry powder inhaler
0301011R0AAAQAQ
|
Salbutamol | Salbutamol | Respiratory System | 14,465 |
|
Phyllocontin Continus 225mg tablets
0301030C0BCAAAE
|
Phyllocontin | Aminophylline hydrate | Respiratory System | 14,349 |
|
Fluticasone 50micrograms/dose inhaler CFC free
0302000N0AABHBH
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 14,218 |
|
Fluticasone 125microg / Formoterol 5microg/dose inh CFC free
0302000N0AABJBJ
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 13,955 |
|
Serevent 25micrograms/dose Evohaler
0301011U0BBAFAH
|
Serevent | Salmeterol | Respiratory System | 13,522 |
|
Ipratropium bromide 500micrograms/2ml neb liq ud vials
0301020I0AAACAC
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | 13,408 |
|
Airomir 100micrograms/dose inhaler
0301011R0BMAAAP
|
Airomir | Salbutamol | Respiratory System | 13,236 |
|
Combisal 25micrograms/dose / 50micrograms/dose inhaler
0302000N0BLAABE
|
Combisal | Fluticasone propionate (Inhalation) | Respiratory System | 12,957 |
|
Pulmicort 100 Turbohaler
0302000K0BBAKAK
|
Pulmicort | Budesonide | Respiratory System | 12,758 |
|
Fluticasone 250microg / Formoterol 10microg/dose inh CFCfree
0302000N0AABKBK
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 12,745 |
|
Tiotropium bromide 10microgram inhalation pdr caps with dev
0301020Q0AAADAD
|
Tiotropium bromide | Tiotropium bromide | Respiratory System | 12,477 |
|
Acrivastine 8mg capsules
0304010A0AAAAAA
|
Acrivastine | Acrivastine | Respiratory System | 12,118 |
|
Beclometasone 50micrograms/dose inhaler CFC free
0302000C0AABEBE
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 12,023 |
|
Bibecfo 100micrograms/dose / 6micrograms/dose inhaler
0302000C0BWAABX
|
Bibecfo (old) | Beclometasone dipropionate | Respiratory System | 11,496 |
|
Combisal 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BLACBG
|
Combisal | Fluticasone propionate (Inhalation) | Respiratory System | 11,479 |
|
Budesonide 100microg / Formoterol 6microg/dose dry pdr inh
0302000K0AAALAL
|
Budesonide (Inhalation) | Budesonide | Respiratory System | 11,317 |
|
Fluticasone 125micrograms/dose inhaler CFC free
0302000N0AABABA
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 10,964 |
|
Beclometasone 100microg/Formoterol 6microg/dose dry pdr inh
0302000C0AABYBY
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 10,919 |
|
Fluticasone propionate 500microg/Salmeterol 50microg/dose
0302000N0AAAZAZ
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 10,852 |
|
AirFluSal Forspiro 50microg / 500microg/dose dry pdr inh
0302000N0BGAAAZ
|
AirFluSal | Fluticasone propionate (Inhalation) | Respiratory System | 10,841 |
|
Kelhale 50micrograms/dose inhaler
0302000C0BSAABE
|
Kelhale | Beclometasone dipropionate | Respiratory System | 10,825 |
|
Fobumix Easyhaler 80microg/dose / 4.5microg/dose dry pdr inh
0302000K0BIADAL
|
Fobumix | Budesonide | Respiratory System | 10,771 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.